Loading...
Loading...
In a report published Friday, Jefferies & Company upgraded its rating on Health Net
HNT to Hold, and raised its price target from $17.00 to $26.00.
Jefferies noted, “HNT's pricing agreement with California officials is a substantial risk mitigator. It narrows downside earnings risk, improves 2013 EPS, and addresses two key risks (SPDs; Duals) that were elements of our Underperform thesis. HNT is also making progress on a third concern, Commercial performance. We are upgrading to Hold and raising our PT to $26 on the improved outlook. This note analyzes scenarios for 2013 EPS that range to mid-$2.”
Health Net closed on Thursday at $25.35.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in